These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22279785)

  • 1. [Correction of immunometabolic disorders in chronic bacterial prostatitis].
    Shatokhin MN; Teodorovich OV; Konoplia AI; Gavriliuk VP; Mavrin MIu; Krasnov AV
    Urologiia; 2011; (5):39-42. PubMed ID: 22279785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in endocrine metabolic immune disorders drug targeting: an editorial overview.
    Magrone T; Jirillo E
    Endocr Metab Immune Disord Drug Targets; 2015; 15(1):1-8. PubMed ID: 25800124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic prostatitis, benign prostatic hyperplasia and immunity: the disorders and correction].
    Konoplia AI; Teodorovich OV; Shatokhin MN; Gavriliuk VP; Mavrin MIu
    Urologiia; 2013; (4):99-103. PubMed ID: 24159776
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correction of local immunometabolic disturbances combined with chronic prostatitis in prostatic adenoma].
    Teodorovich OV; Shatokhin MN; Mal'tsov VN; Konoplia AI; Loktiononv AL; Krasnov AV
    Urologiia; 2010; (5):22-6. PubMed ID: 21254636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of immunocorrective therapy on immunological indices in patients with chronic bacterial prostatitis].
    Repin EV; Dolgikh VT; Dolgikh TN; Ershov AV; Repina TV
    Urologiia; 2011; (6):50-4. PubMed ID: 22448482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical immunological rationale of interferon therapy in chronic bacterial prostatitis].
    Kamalov AA; Efremov EA; Dorofeev SD; Tret'iakov AA; Okhobotov DA; Mel'nik IaI; Bedretdinova DA
    Urologiia; 2010; (1):34-8. PubMed ID: 20886729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunocorrecting therapy of chronic bacterial prostatitis].
    Novikov AI; Zaezzhalkin VV; Kucherov VA; Frolov SIu
    Urologiia; 2010; (4):44, 46-8. PubMed ID: 20973134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative efficacy of immunomodulation treatment schemes in patients with herpetic prostatitis].
    Aboian IA; Tsurikova EIu
    Urologiia; 2008; (4):37-40. PubMed ID: 19058363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Upgrading of clinicoimmunological effectiveness of combined treatment in patients with chronic prostatitis].
    Bratchikov OI; Shestakov SG; Shumakova EA; Makhov SV
    Urologiia; 2008; (2):44-8. PubMed ID: 18572770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of oxidant-antioxidant homeostasis in patients with eczema treated using different methods].
    Stepan N; Denysenko O
    Georgian Med News; 2015 May; (242):39-45. PubMed ID: 26042446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selzink plus study in patients with chronic non-infectious prostatitis and abnormal fertility].
    Sivkov AV; Oshchepkov VN; Evdokimov VV; Keshishev NG; Skabko OV
    Urologiia; 2011; (5):27-8, 30-3. PubMed ID: 22279783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of immunomodulators, antioxidants and hepatoprotectors for the correction of the liver, erythrocites and the immune system disorders in chronic ethanol intoxication].
    Dolgareva SA; Sorokin AV; Konoplya NA; Bushmina ON; Bystrova NA; Ovod AI
    Biomed Khim; 2018 Aug; 64(4):360-367. PubMed ID: 30135284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Olifen action on mutagenesis in human lymphocytes].
    Mazurov VI; Filev LV; Sinopal'nikov DO; Enokhin SF; Petrova TN; Medvedev IV; Volchek IV; Bykhovets IV
    Klin Med (Mosk); 1996; 74(9):58-61. PubMed ID: 9121094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis].
    Seregin SP; Bratchikov OI; Konoplia AI; Shestakov SG; Dolzhenkov SD; Novikov AV; Shatokhin MN; Kotov AV
    Urologiia; 2002; (4):14-6. PubMed ID: 12357892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correction of complement system failure in patients with chronic prostatitis].
    Teodorovich OV; Shatokhin MN; Mykolaenko TV; Konoplia AI; Krasnov AV; Mavrin MIu; Meshanin NV
    Urologiia; 2011; (4):29-32. PubMed ID: 22066238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of afala in the therapy of chronic prostatitis.
    Tkachuk VN
    Bull Exp Biol Med; 2009 Aug; 148(2):312-4. PubMed ID: 20027356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of the use of antioxidant preparation mexidol in comprehensive treatment of inflammatory diseases of parodontium].
    Garazha NN; Garus IaN; Ivashova AV; Sakuro AA
    Stomatologiia (Mosk); 2006; 85(6):19-21. PubMed ID: 17310943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mexidol preparation influence upon lipids peroxide oxidation and oral fluid antioxidant system activity in patients with chronic generalized parodontitis and arterial hypertension].
    Kazarina LN; Vdovina LV; Dubrovskaia EN
    Stomatologiia (Mosk); 2010; 89(2):18-21. PubMed ID: 20517245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coenzyme Q-10: efficacy, safety, and use.
    Jones K; Hughes K; Mischley L; McKenna DJ
    Altern Ther Health Med; 2002; 8(3):42-55; quiz 56, 138. PubMed ID: 12017500
    [No Abstract]   [Full Text] [Related]  

  • 20. [Related immunologic mechanisms of chronic prostatitis: Advances in studies].
    Liu Y; Chen XG; Liang CZ
    Zhonghua Nan Ke Xue; 2017 Jul; 23(7):652-655. PubMed ID: 29723461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.